02 Jun, 2025 Press Releases Curevo Enrolls First Participants in Phase 2 Extension Trial by curevovaccine
17 Mar, 2025 Press Releases Curevo Raises $110 Million to Advance Amezosvatein Shingles Vaccine by curevovaccine
12 Jan, 2025 Press Releases Curevo Announces Positive Updated Phase 2 Data for Amezosvatein Shingles Vaccine by curevovaccine
08 Jan, 2025 Press Releases Curevo Vaccine to present at the 43rd Annual J.P. Morgan Healthcare Conference by curevovaccine
16 Oct, 2024 Press Releases Curevo Vaccine Presents Amezosvatein Shingles Vaccine Data at ID Week by curevovaccine
07 Apr, 2024 Press Releases Dr. Chi Li Joins Curevo Vaccine as Chief Regulatory Officer by curevovaccine
07 Jan, 2024 Press Releases Curevo Vaccine Announces Positive Topline Results from Phase 2 Trial of Amezosvatein, a Next-Generation Vaccine for Shingles, Head-to-Head vs. Shingrix by curevovaccine
11 Apr, 2023 Press Releases Guy De La Rosa, MD, Joins Curevo Vaccine as Chief Medical Officer by curevovaccine
16 Nov, 2022 Press Releases Curevo Vaccine Announces $26 Million Series A1 Financing to Support Clinical Development of Next-Generation Subunit Vaccines by curevovaccine
